Sucampo Pharmaceuticals, Inc. to Host Analyst Meeting September 28th

Published: Sep 17, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that it plans to host an Analyst Meeting, open to members of the professional investment community, on September 28, 2012, from 8:00 to 11:00 am in New York City. Members of Sucampo’s management team will present detailed descriptions of the Company’s prostone technology, its pipeline of development candidates and provide commercial updates for its two FDA-approved prostone-based drugs, AMITIZA® and RESCULA®.

Back to news